Search Results - "VAN DER MEER, M. J. M"

The ecological effects of selective decontamination of the digestive tract (SDD) on antimicrobial resistance: a 21-year longitudinal single-centre study by Buitinck, Sophie, Jansen, Rogier, Rijkenberg, Saskia, Wester, Jos P J, Bosman, Rob J, van der Meer, Nardo J M, van der Voort, Peter H J

“…The long-term ecological effects on the emergence of antimicrobial resistance at the ICU level during selective decontamination of the digestive tract (SDD)…”
Get full text

Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism by Boon, Gudula J A M, Rein, Nienke van, Bogaard, Harm Jan, Ende-Verhaar, Yvonne M, Huisman, Menno V, Kroft, Lucia J M, Meer, Felix J M van der, Meijboom, Lilian J, Symersky, Petr, Vonk Noordegraaf, Anton, Klok, Frederikus A

“…The pathophysiology of chronic thromboembolic pulmonary hypertension (CTEPH) is not fully understood. Poor-quality anticoagulation may contribute to a higher…”
Get full text

Advanced Practice Providers as Leaders of a Rapid Response Team: A Prospective Cohort Study by Kreeftenberg, Herman G, de Bie, Ashley J R, Aarts, Jeroen T, Bindels, Alexander J G H, van der Meer, Nardo J M, van der Voort, Peter H J

“…In view of the shortage of medical staff, the quality and continuity of care may be improved by employing advanced practice providers (APPs). This study aims…”
Get full text

Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case‐cohort by Camilleri, Eleonora, Ghobreyal, Mira, Bos, Mettine H. A., Reitsma, Pieter H., Van Der Meer, Felix J. M., Swen, Jesse J., Cannegieter, Suzanne C., Rein, Nienke

“…Background Major bleeding occurs annually in 1%–3% of patients on vitamin K antagonists (VKAs), despite close monitoring. Genetic variants in proteins involved…”
Get full text

The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment by Kooiman, Judith, van Hagen, Nadja, Iglesias Del Sol, Antonio, Planken, Erwin V, Lip, Gregory Y H, van der Meer, Felix J M, Cannegieter, Suzanne C, Klok, Frederikus A, Huisman, Menno V

“…The HAS-BLED score enables a risk estimate of major bleeds in patients with atrial fibrillation on vitamin K-antagonists (VKA) treatment, but has not been…”
Get full text

Trauma Patient Volume and the Quality of Care: A Scoping Review by Foppen, Wouter, Claassen, Yvette, Falck, Debby, van der Meer, Nardo J. M

“…Background: Healthcare stakeholders in the Netherlands came to an agreement in 2022 to deal with present and future challenges in healthcare. Among others,…”
Get full text

Are Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder Different Manifestations of One Overarching Disorder? Cognitive and Symptom Evidence From a Clinical and Population-Based Sample by van der Meer, Jolanda M.J., M.Sc, Oerlemans, Anoek M., M.Sc, van Steijn, Daphne J., M.Sc, Lappenschaar, Martijn G.A., M.D, de Sonneville, Leo M.J., Ph.D, Buitelaar, Jan K., M.D., Ph.D, Rommelse, Nanda N.J., Ph.D

“…Objective Autism spectrum disorders (ASD) and attention-deficit/hyperactivity disorder (ADHD) frequently co-occur. Given the heterogeneity of both disorders,…”
Get full text

Correction: Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism by Boon, Gudula J. A. M, van Rein, Nienke, Bogaard, Harm Jan, Ende-Verhaar, Yvonne M, Huisman, Menno V, Kroft, Lucia J. M, van der Meer, Felix J. M, Meijboom, Lilian J, Symersky, Petr, Noordegraaf, Anton Vonk, Klok, Frederikus A

“…[This corrects the article DOI: 10.1371/journal.pone.0232354.]…”
Get full text

Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists by van Rein, Nienke, Lijfering, Willem M, Bos, Mettine H A, Herruer, Martien H, Vermaas, Helga W, van der Meer, Felix J M, Reitsma, Pieter H

“…Risk scores for patients who are at high risk for major bleeding complications during treatment with vitamin K antagonists (VKAs) do not perform that well…”
Get full text

Effect of On-Demand vs Routine Nebulization of Acetylcysteine With Salbutamol on Ventilator-Free Days in Intensive Care Unit Patients Receiving Invasive Ventilation: A Randomized Clinical Trial by van Meenen, David M. P, van der Hoeven, Sophia M, Binnekade, Jan M, de Borgie, Corianne A. J. M, Merkus, Maruschka P, Bosch, Frank H, Endeman, Henrik, Haringman, Jasper J, van der Meer, Nardo J. M, Moeniralam, Hazra S, Slabbekoorn, Mathilde, Muller, Marcella C. A, Stilma, Willemke, van Silfhout, Bart, Neto, Ary Serpa, ter Haar, Hans F. M, Van Vliet, Jan, Wijnhoven, Jan Willem, Horn, Janneke, Juffermans, Nicole P, Pelosi, Paolo, Gama de Abreu, Marcelo, Schultz, Marcus J, Paulus, Frederique

“…IMPORTANCE: It remains uncertain whether nebulization of mucolytics with bronchodilators should be applied for clinical indication or preventively in intensive…”
Get full text

IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells by Van der Meer, J. M. R., Maas, R. J. A., Guldevall, K., Klarenaar, K., de Jonge, P. K. J. D., Evert, J. S. Hoogstad-van, van der Waart, A. B., Cany, J., Safrit, J. T., Lee, J. H., Wagena, E., Friedl, P., Önfelt, B., Massuger, L. F., Schaap, N. P. M., Jansen, J. H., Hobo, W., Dolstra, H.

“…Allogeneic natural killer (NK) cell transfer is a potential immunotherapy to eliminate and control cancer. A promising source are CD34 + hematopoietic…”
Get full text

Risk of infections in patients with gout: a population-based cohort study by Spaetgens, B., de Vries, F., Driessen, J. H. M., Leufkens, H. G., Souverein, P. C., Boonen, A., van der Meer, J. W. M., Joosten, L. A. B.

“…To investigate the risk of various types of infections (pneumonia and urinary tract infection (UTI)), and infection-related mortality in patients with gout…”
Get full text

Recognition of facial emotion and affective prosody in children with ASD (+ADHD) and their unaffected siblings by Oerlemans, Anoek M., van der Meer, Jolanda M. J., van Steijn, Daphne J., de Ruiter, Saskia W., de Bruijn, Yvette G. E., de Sonneville, Leo M. J., Buitelaar, Jan K., Rommelse, Nanda N. J.

“…Autism is a highly heritable and clinically heterogeneous neuropsychiatric disorder that frequently co-occurs with other psychopathologies, such as…”
Get full text

Review: Infectious Diseases and Coagulation Disorders by van Gorp, E. C. M., Suharti, C., ten Cate, H., Dolmans, W. M. V., van der Meer, J. W. M., ten Cate, J. W., Brandjes, D. P. M.

“…Infection, both bacterial and nonbacterial, may be associated with coagulation disorders, resulting in disseminated intravascular coagulation and multiorgan…”
Get full text

The carbohydrate-binding plant lectins and the non-peptidic antibiotic pradimicin A target the glycans of the coronavirus envelope glycoproteins by van der Meer, F. J. U. M., de Haan, C. A. M., Schuurman, N. M. P., Haijema, B. J., Verheije, M. H., Bosch, B. J., Balzarini, J., Egberink, H. F.

“…Objectives Many enveloped viruses carry carbohydrate-containing proteins on their surface. These glycoproteins are key to the infection process as they are…”
Get full text

Recurrence risk after anticoagulant treatment of limited duration for late, second venous thromboembolism by van der Hulle, Tom, Tan, Melanie, den Exter, Paul L, van Roosmalen, Mark J G, van der Meer, Felix J M, Eikenboom, Jeroen, Huisman, Menno V, Klok, Frederikus A

“…Patients with a second venous thromboembolism generally receive anticoagulant treatment indefinitely, although it is known that the recurrence risk diminishes…”
Get full text

Good manufacturing practice production of CD34+ progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia by de Jonge, P. K. J. D., van Hauten, P. M. M., Janssen, L. D., de Goede, A. L., Berrien-Elliott, M. M., van der Meer, J. M. R., Mousset, C. M., Roeven, M. W. H., Foster, M., Blijlevens, N., Hobo, W., Fehniger, T. A., Jansen, J. H., Schaap, N. P. M., Dolstra, H.

“…Allogeneic natural killer (NK) cell-based immunotherapy is a promising, well-tolerated adjuvant therapeutic approach for acute myeloid leukemia (AML). For…”
Get full text

Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series by Flikweert, Antine W., Grootenboers, Marco J.J.H., Yick, David C.Y., du Mée, Arthur W.F., van der Meer, Nardo J.M., Rettig, Thijs C.D., Kant, Merijn K.M.

“…Pathological data of critical ill COVID-19 patients is essential in the search for optimal treatment options. We performed postmortem needle core lung biopsies…”
Get full text

Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy by Rombouts, Eva K., Rosendaal, Frits R., Van Der Meer, Felix J. M.

“…Summary It is unclear what advice should be given to patients using vitamin K antagonists with respect to dietary vitamin K intake. We performed a nested…”
Get full text

Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study by Toorop, Myrthe M. A., Rein, Nienke, Nierman, Melchior C., Vermaas, Helga W., Huisman, Menno V., Meer, Felix J. M., Cannegieter, Suzanne C., Lijfering, Willem M.

“…Background Direct oral anticoagulants (DOACs) do not require concentration monitoring. However, whether DOAC concentrations are stable and their variation…”
Get full text